Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"BMC cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Wang%2C+Mingxia%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
/vufind/Search/Results?lookfor=%22Wang%2C+Mingxia%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
Search /vufind/Search2/Results?lookfor=%22Wang%2C+Mingxia%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
PubPharm (6)
1
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer : a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
2
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
3
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
4
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer : a systematic review and meta-analysis
enthalten in:
BMC cancer
| 2019
von
Chen, S.
|
Liang, Y.
|
Feng, Z.
| +1
Wird geladen...
5
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis
enthalten in:
BMC cancer
| 2019
von
Chen, S.
|
Liang, Y.
|
Feng, Z.
| +1
Wird geladen...
6
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysis
enthalten in:
BMC cancer
| 2019
von
Chen, S.
|
Liang, Y.
|
Feng, Z.
| +1
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: BMC cancer
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
BMC cancer
Thema
3
BPI-9016M
3
Dual-targeted therapy
3
Efficacy
3
HER2-positive breast cancer
3
Mesenchymal-epithelial transition factor
3
Molecular targeted therapy
3
Non-small-cell lung cancer
3
Pertuzumab
3
Pharmacokinetics
3
Safety
3
Trastuzumab
3
Trastuzumab emtansine
2
EC 2.7.10.1
2
Journal Article
1
15H5577CQD
1
Ado-Trastuzumab Emtansine
1
Antibodies, Monoclonal, Humanized
1
Antineoplastic Agents, Immunological
1
Clinical Trial, Phase I
1
Docetaxel
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...